Skip to main content
. 2024 Dec 10;17:5917–5926. doi: 10.2147/JMDH.S491697

Table 1.

Baseline Characteristics of Patients in the Training, Internal Validation and External Validation Dataset

Training Cohort (n=275) P Internal Validation Cohort (n=119) External Validation Cohort (n=122)
Unruptured (n=128) Raptured (n=147) Unruptured (n=55) Raptured (n=64) Unruptured (n=50) Raptured (n=72)
Age 64.37±12.51 57.69±11.28 <0.001 62.67±12.05 56.14±11.48 69.08±10.06 58.61±15.29
Sex 0.731
Male 54(42.2%) 59(40.1%) 24(43.6%) 29(45.3%) 23(46.0%) 22(30.6%)
Female 74(57.8%) 88(59.9%) 31(56.4%) 35(54.7%) 27(54.0%) 50(69.4%)
Hypertension 0.018
Presence 80(62.5%) 71(48.3%) 31(56.4%) 22(34.4%) 35(70.0%) 33(45.8%)
Absence 48(37.5%) 76(51.7%) 24(43.6%) 42(65.6%) 15(30.0%) 39(54.2%)
Smoking 0.287
Presence 35(27.3%) 32(21.8%) 10(18.2%) 12(18.8%) 16(32.0%) 13(18.1%)
Absence 93(72.7%) 115(78.2%) 45(81.8%) 52(81.2%) 34(68.0%) 59(81.9%)
Coronary artery disease 0.001
Presence 1(0.8%) 1(0.7%) 0 0 13(26.0%) 18(25.0%)
Absence 127(99.2%) 146(99.3%) 55(100%) 55(100%) 37(74.0%) 54(75.0%)
Ischemic stroke 0.158
Presence 2(1.6%) 0(0.0%) 2(3.6%) 2(3.1%) 7(14.0%) 3(4.2%)
Absence 126(98.4%) 147(100.0%) 53(96.4%) 62(96.9%) 43(86.0%) 69(95.8%)
Multiplicity <0.001
Presence 48(37.5%) 20(13.6%) 22(40.0%) 11(17.2%) 8(16.0%) 15(20.8%)
Absence 80(62.5%) 127(86.4%) 33(60.0%) 53(82.8%) 42(84.0%) 57(79.2%)
Location <0.001
ICA 37(28.9%) 14(9.5%) 8(14.5%) 39(4.7%) 18(36%) 5(6.9%)
AcoA 27(21.1%) 60(40.8%) 16(29.1%) 27(42.2%) 8(16%) 27(37.5%)
PcoA 28(21.9%) 54(36.7%) 17(30.9%) 17(26.5%) 15(30%) 31(43.1%)
MCA 28(21.9%) 14(9.5%) 10(18.2%) 14(21.9%) 7(14%) 6(8.3%)
Others 8(6.2%) 5(3.5%) 4(7.3%) 3(4.7%) 2(4%) 3(4.2%)